Summary
- Current Price
- As of today, MLTX price is $14.94, down -1.26% in the most recent trading session on
- Current Price All-Time High
- MLTX price is currently -77.01% below its historical high of $64.98 set on
- Market Cap
- MLTX current market cap is $1B, down -65.79% year-over-year
- Revenue
- MLTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for MLTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | MoonLake Immunotherapeutics |
| Ticker | NASDAQ: MLTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Switzerland |
| IPO | |
| Indexes | Not included |
| Website | moonlaketx.com |
| Employees | 100 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $14.94 | |
| Price, 1D Change | -1.26% | |
| $1B | ||
| - | ||
| - | ||
| 1.12 | ||
| $0.00 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.53 | ||
| EPS, 1Y Change | -86.40% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | HLXA | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$3.53 | ||
| EPS Estimate | -$3.33 | N/A |
| EPS Est. Change | +5.57% | N/A |
| $0.00 | ||
| Revenue Estimate | - | N/A |
| Revenue Est. Change | - | N/A |
| Current Price | $14.94 | |
| Price Target | $30.00 | - |
| Price Tgt. Change | +100.80% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.72 | -$1.89 | -10.03% | |
| -$3.60 | -$3.53 | +2.04% | |
| -$3.33 | N/A | +5.57% | |
| -$3.34 | N/A | +5.22% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $19.04M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $14.94 | |
| $16.87 | ||
| $18.14 | ||
| $20.18 | ||
| $17.35 | ||
| -$0.87 | ||
| 1.12 | ||
| $0.74 | ||
| 34.45 | ||
| 36.93% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $0.00 | ||
| -$3.53 | ||
| -$2.62M | ||
| - | ||
| -$244.83M | ||
| - | ||
| -$230.32M | ||
| - | ||
| -$242.22M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.25 | ||
| 9.27 | ||
| 9.27 | ||
| - | ||
| - | ||
| 3.99 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| - | ||
| 2.97 | ||
| -3.15 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $304.48M | ||
| $393.97M | ||
| $424.43M | ||
| $421.69M | ||
| $119.95M | ||
| $45.48M | ||
| $75.71M | ||
| $1.23M | ||
| $0.00 |
Expenses
| Metric | Value | Date |
|---|---|---|
| $227.32M | ||
| $242.22M | ||
| $2.62M | ||
| $0.00 | ||
| $2.62M | ||
| $0.00 | ||
| $611.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$196.01M | ||
| $202.99M | ||
| $146.00M | ||
| $35.00K | ||
| -$196.04M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Leerink Partners | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| Wolfe Research | → | |
| Rothschild & Co | → |
Analyst sentiment
Institutional ownership
No data
Screeners with MLTX
FAQ
- What is the ticker symbol for MoonLake Immunotherapeutics?
- The ticker symbol for MoonLake Immunotherapeutics is NASDAQ:MLTX
- Does MoonLake Immunotherapeutics pay dividends?
- No, MoonLake Immunotherapeutics does not pay dividends
- What sector is MoonLake Immunotherapeutics in?
- MoonLake Immunotherapeutics is in the Healthcare sector
- What industry is MoonLake Immunotherapeutics in?
- MoonLake Immunotherapeutics is in the Biotechnology industry
- What country is MoonLake Immunotherapeutics based in?
- MoonLake Immunotherapeutics is headquartered in Switzerland
- When did MoonLake Immunotherapeutics go public?
- MoonLake Immunotherapeutics initial public offering (IPO) was on October 20, 2020
- Is MoonLake Immunotherapeutics in the S&P 500?
- No, MoonLake Immunotherapeutics is not included in the S&P 500 index
- Is MoonLake Immunotherapeutics in the NASDAQ 100?
- No, MoonLake Immunotherapeutics is not included in the NASDAQ 100 index
- Is MoonLake Immunotherapeutics in the Dow Jones?
- No, MoonLake Immunotherapeutics is not included in the Dow Jones index
- When was MoonLake Immunotherapeutics last earnings report?
- MoonLake Immunotherapeutics's most recent earnings report was on August 10, 2026
- When does MoonLake Immunotherapeutics report earnings?
- The next expected earnings date for MoonLake Immunotherapeutics is November 5, 2026
Data Sources & References
- MLTX Official Website www.moonlaketx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1821586/000182158626000002/0001821586-26-000002-index.htm
- MLTX Profile on Yahoo Finance finance.yahoo.com/quote/MLTX
- MLTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mltx